| Authors: |
Tang C; Department of Genitourinary Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ctang1@mdanderson.org., Seo A; Department of Genitourinary Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sherry AD; Department of Genitourinary Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Mayo Clinic, Rochester, MN, USA., Yang P; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hara K; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sircar K; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Genovese G; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jonasch E; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shah AY; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zurita AJ; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kovitz CA; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Campbell M; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Su S; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang J; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ratzel S; Myriad Genetics, Salt Lake City, UT, USA., Acevedo A; Myriad Genetics, Salt Lake City, UT, USA., LaBella M; Myriad Genetics, Salt Lake City, UT, USA., Battey CJ; Myriad Genetics, Salt Lake City, UT, USA., Steiner C; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Urology, University Hospital Leipzig, Leipzig, Germany., Ascione L; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Liu X; Harvard Medical School, Boston, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA., Hannan R; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Shapiro DD; Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA., Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Tannir NM; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Msaouel P; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xu W; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. |
